Provider
QP62-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Interleukin 5 (IL-5) Inhibitors
Program effective Date: Jun 26, 2019
Search Results
Displaying 2761 - 2770 of 3655 results
Provider
QP60-19 2019 Blue Cross Basic Seminars
Program effective Date: Jun 26, 2019
Provider
QP61-19 Availity Portal Authorization Frequently Asked Questions
Program effective Date: Jun 26, 2019
Provider
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Program effective Date: Jun 26, 2019
Provider
QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection
Program effective Date: Jun 12, 2019
Provider
QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids
Program effective Date: Jun 12, 2019
Provider
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Program effective Date: Jun 12, 2019
Provider
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Program effective Date: Jun 12, 2019
Provider
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Program effective Date: Jun 12, 2019
Provider
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Program effective Date: Jun 12, 2019